Effects of lithium on blood glucose and insulin in individuals with bipolar disorder: A systematic review
Journal of Affective Disorders · 2026-07 · 404 · 120891
DOI: 10.1016/j.jad.2025.120891 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Affective Disorders, 2026-07. Verfasst von David Kanter-Eivin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, McMaster University, Canada. Hauptthemen laut MEDLINE: Bipolar Disorder, Blood Glucose, Insulin, Lithium Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Lithium is the gold-standard pharmacotherapy for both acute episodes and long-term management of bipolar disorder (BD). Lithium treatment is associated with metabolic changes including weight gain; however, the exact mechanisms mediating weight increase are poorly understood. This systematic review assesses the effects of lithium on glucose, glucose-tolerance and insulin in persons with BD. METHODS: A systematic search was conducted on PubMed, MEDLINE, Embase, CENTRAL, APA PsychINFO, Scopus and Web of Science. Primary studies assessing validated metrics of serum glucose or insulin in bipolar patients receiving lithium treatment were included. RESULTS: 16 studies were included in this review. Fasting plasma glucose (FPG) was the most studied metabolic biomarker. Most studies did not report an association between lithium and changes in FPG. Lithium treatment did increase glucose tolerance in the short-term, however most short-term effects appear to be transient and do not persist. LIMITATIONS: There is a lack of a consistent criteria for BD across the reviewed studies. Many included studies lack controls and do not stratify for relevent metabolic factors such as body mass index (BMI) and age. CONCLUSIONS: Lithium does not appear to consistently affect FPG in persons with BD. Current evidence does not suggest that lithium directly and consistently affects FPG; instead changes to FPG in persons receiving lithium may be indirectly affected by BMI, age or mood status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael G. DeGroote School of Medicine, McMaster University, Canada.
- Faculty of Health Sciences, McMaster University, Canada.
- Brain and Cognition Discovery Foundation, Canada.
- Brain and Cognition Discovery Foundation, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
- Brain and Cognition Discovery Foundation, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada.
- Brain and Cognition Discovery Foundation, Canada; Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.
Zitieren
APA
Kanter-Eivin, D., Blinkov, K., MacDonald, S., Gibson, J., Pimenta, S., Teopiz, K., Lau, O., Kwan, A. T. H., Le, G. H., Wong, S., Rosenblat, J. D., & McIntyre, R. S. (2026). Effects of lithium on blood glucose and insulin in individuals with bipolar disorder: A systematic review. Journal of Affective Disorders, 404, 120891. https://doi.org/10.1016/j.jad.2025.120891
Vancouver
Kanter-Eivin D, Blinkov K, MacDonald S, Gibson J, Pimenta S, Teopiz K, et al. Effects of lithium on blood glucose and insulin in individuals with bipolar disorder: A systematic review. Journal of Affective Disorders. 2026;404:120891. doi:10.1016/j.jad.2025.120891
BibTeX
@article{KanterEivin2026,
author = {Kanter-Eivin, David and Blinkov, Konstantin and MacDonald, Sadie and Gibson, Jada and Pimenta, Sarah and Teopiz, Kayla and Lau, Olivia and Kwan, Angela T H and Le, Gia Han and Wong, Sabrina and Rosenblat, Joshua D and McIntyre, Roger S},
title = {Effects of lithium on blood glucose and insulin in individuals with bipolar disorder: A systematic review},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {404},
pages = {120891},
doi = {10.1016/j.jad.2025.120891}
}
EUVIMED